P
Parmax Pharma
PARMAX Share Price
Healthcare28.59
as on 13 Mar 2026 at 15:28
BSE
Market Cap
₹11 Cr
PE Ratio
-2.00
ROCE
-31.66%
PARMAX Fundamentals
Company Valuation
Market Cap (₹ Cr.)
11
PE Ratio
-2.00
PB Ratio
-1.85
Dividend Yield
-
ROE
105.30%
ROCE
-31.66%
Book Value (₹)
-14.81
Face Value (₹)
10.00
Share Holding Pattern
| Held By | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|
| Promoters | 30.80% | 30.80% | 30.80% | 30.80% | 30.80% |
| Domestic Institutional Investors (DII) | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Foreign Institutional Investors (FII) | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Investors | 63.12% | 63.10% | 63.10% | 63.09% | 63.08% |
| Government | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Promoters
Domestic Institutional Investors (DII)
Foreign Institutional Investors (FII)
Public Investors
Government
PARMAX Investment Returns
Short Term
1 Week
1 Month
3 Months
6 Months
9 Months
Long Term
1 Year
2 Years
3 Years
4 Years
5 Years
- In Short Term
- In Long term
1 Week
1 Month
3 Months
6 Months
9 Months
Create Wealth in Longterm with Weekly and Monthly SIP in Stocks.
Stock & Sector Information
Sector
Healthcare
Sub Sector
Pharmaceuticals
Company Classification
Microcap
BSE Scrip Code
540359
NSE Scrip Name
PARMAX
ISIN
INE240T01014



